A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S ...
A pharmacy terminated from OptumRx Inc.'s benefits network must arbitrate its state and federal insurance and tort law claims against the pharmacy benefits manager, even though they never formally ...
The charges in this lawsuit accuse Optum Rx - the PBM who determined Cole Schmidtknecht’s health plan - of negligence and punitive damages that led to the death of their son. The family’s ...
After a low-key announcement at CES 2025, AMD has given an update on when to expect its next-generation graphics cards. The new AMD Radeon RX 9070 and 9070 XT now have a launch month, according to ...
AMD has confirmed RX 9070 models will be on shelves in March 2025 This runs against rumors that suggested a late January launch PC gamers aren’t happy, particularly as stock of RDNA 4 graphics ...
TL;DR: AMD has announced that its RDNA 4 desktop gaming GPUs, including the Radeon 9000 Series, will launch in March 2025. This timing follows NVIDIA's release of the GeForce RTX 5070 series ...
WASHINGTON - President-elect Donald Trump is in Washington, D.C. Sunday for his ‘Victory Rally’ at Capital One Arena. Trump will be sworn in as the 47th president of the United States on ...
TL;DR: AMD's upcoming Radeon RX 9070 XT and RX 9070 graphics cards are rumored to be priced at $599 and $499, respectively, offering competitive pricing against NVIDIA's GeForce RTX 50 series.
AMD has been curiously tight-lipped about the details of its recently-announced new GPUs, but this AMD Radeon RX 9070 XT specs leak appears to reveal what the company has waiting in the wings.
The Federal Trade Commission (FTC) released a report finding that OptumRX, Express Scripts, and CVS Caremark Rx are engaged in widespread price gouging, according to Fortune. The investigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results